ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselNOUSCOM AG
NOUSCOM AG Logo
Verified· 3 sources

NOUSCOM AG

Summary

About the company

The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Neoantigen-Based Cancer Immunotherapies
Cancer immunotherapies using viral vectors and neoantigens, including an off-the-shelf therapy for dMMR/MSI tumors and a personalized neoantigen vaccine.
Personalized Cancer Vaccines
Personalized cancer vaccines based on patient-specific neoantigens from tumor mutanomes, with rapid manufacturing from biopsy to released product.
Off-the-Shelf Cancer Immunotherapies
Standardized cancer immunotherapies with shared frameshift neoantigens for dMMR/MSI tumors, used in combination with pembrolizumab and in clinical studies.
Targeted Oncolytic Viruses
Targeted armed oncolytic viruses for solid tumors, delivered locally or systemically, with immunomodulatory transgenes to enhance anti-tumor activity.
Press

Media

May 9, 2025Media
Milestones achievements for life sciences startups
startupticker.ch
March 26, 2024Media
Nouscom secures additional funding from Angelini Ventures
startupticker.ch
November 14, 2023Media
Nouscom raises CHF65 million in oversubscribed Series C financing round
startupticker.ch
February 27, 2020Media
New bosses for life sciences companies
startupticker.ch
May 17, 2016Media
New company of former Okairos founders bags €12 million
startupticker.ch
Comparisons

NOUSCOM AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NOUSCOM AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NOUSCOM AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bäumleingasse 18
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-243.080.729
Founded
2015 · 11 years
Last commercial register change
September 4, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once NOUSCOM AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

BE
Bio-Rad Europe GmbH
Basel
SB
SOTIO Biotech AG
Basel
MS
Moderna Switzerland GmbH
Basel
FA
FimmCyte AG
Basel
CL
Caris Life Sciences Switzerland Holdings GmbH
Basel
FT
FoRx Therapeutics AG
Basel
SC
St. Clara Forschung AG
Basel
KI
Kuboid Invest AG
Basel